Loading...

DOCS - Doximity, Inc.

Analyst Reiterated Signal for 05-18-2022
Analyst Reiterated/Price Target Changed: DOCS rating Buy by Goldman
Price Target: $72>>56



Stock Signal Information


Signal

Analyst Reiterated Stock
Report Date: 05-18-2022
Symbol: DOCS - Doximity, Inc.
Sector: Healthcare
Industry: Health Information Services
Analyst Reiterated/Price Target Changed: DOCS rating Buy by Goldman
Price Target: $72>>56

  DOCS Technical Chart

Company Contact

Doximity, Inc. (DOCS)
500, 3rd Street
San Francisco, CA
Phone: 650 549 4330
Website: http://www.doximity.com
CEO: Mr. Jeffrey A. Tangney


Company Profile

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.